Investor Stock List
Ranked #3,565 of 8,699 institutional investors

Stempoint Capital LP

New York, NY

$520M
US stock portfolio at live prices · today +$2.0M (+0.38%)
Market closed. Prices as of Nov 20, 6:11 AM ET
Value at quarter end (Q3 2026)
$558M
Change from Q2 2026
−$19.5M (−3.37%)
Positions
68 · 34 new, 25 sold out
Filed
Nov 16, 2026

Not counted in the ranking: call options on $354K of stock, put options on $763K. $87.6M of holdings we could not match to a US listing are included at their reported quarter-end value.

Holdings

Q3 2026 13F, live prices
SRRK 6.67%ERAS 6.18%TRAX 5.55%ABVX 4.33%TNGX 4.32%
StockSharesValue, live% of portfoliovs Q2 2026
SRRK Scholar Rock Holding Corporation688,954$34.7M6.67%Added +188%
ERAS Erasca, Inc.2,260,594$32.1M6.18%Added +44%
TRAX First Tracks Biotherapeutics, Inc.649,924$28.9M5.55%Added +4%
ABVX ABIVAX Société Anonyme279,398$22.5M4.33%Reduced −2%
TNGX Tango Therapeutics, Inc.989,345$22.5M4.32%Reduced −19%
ELVN Enliven Therapeutics, Inc.330,476$15.3M2.95%Reduced −5%
ADPT Adaptive Biotechnologies Corporation463,551$13.0M2.50%New
SYRE Spyre Therapeutics, Inc.132,238$12.9M2.48%Added +24%
SRZN Surrozen, Inc.418,527$12.8M2.47%Reduced −31%
DNTH Dianthus Therapeutics, Inc.150,776$12.8M2.46%Reduced −25%
PRAX Praxis Precision Medicines, Inc.38,720$12.0M2.31%Added +4%
ONC BeOne Medicines AG25,051$10.0M1.92%New
LLY Eli Lilly and Company6,599$8.9M1.71%New
GRAL GRAIL, Inc.81,924$8.6M1.65%New
XENE Xenon Pharmaceuticals Inc.222,287$8.3M1.60%Added +192%
CCCC C4 Therapeutics, Inc.3,293,376$8.0M1.54%Added +529%
JNJ Johnson & Johnson30,000$8.0M1.54%New
RVMD Revolution Medicines, Inc.50,000$8.0M1.53%Reduced −69%
TRVI Trevi Therapeutics, Inc.552,245$7.6M1.46%New
CYTK Cytokinetics, Incorporated145,760$7.5M1.44%Added +93%
ACRS Aclaris Therapeutics, Inc.2,050,698$7.2M1.38%New
JBIO Jade Biosciences, Inc.471,718$7.1M1.37%New
IMVT Immunovant, Inc.201,334$6.5M1.26%Reduced −27%
OABI OmniAb, Inc.1,204,038$6.1M1.16%New
VRDN Viridian Therapeutics, Inc.187,320$5.9M1.13%New
CERS Cerus Corporation2,967,942$5.6M1.08%New
COGT Cogent Biosciences, Inc.184,173$5.1M0.98%New
GH Guardant Health, Inc.33,527$4.9M0.94%New
ARWR Arrowhead Pharmaceuticals, Inc.109,926$4.8M0.92%Added +180%
SNY Sanofi99,880$4.6M0.88%New
EWTX Edgewise Therapeutics, Inc.111,577$4.6M0.88%New
AURA Aura Biosciences, Inc.647,406$4.5M0.87%Reduced −9%
CGON CG Oncology, Inc.54,791$4.5M0.86%Reduced −66%
VOR Vor Biopharma Inc.200,836$3.7M0.71%New
LBRX LB Pharmaceuticals Inc91,757$3.7M0.71%Added +189%
FTH Faeth Therapeutics, Inc.404,921$3.5M0.68%New
BNTX BioNTech SE42,200$3.4M0.66%New
AVLN Avalyn Pharma Inc.118,000$3.4M0.65%Unchanged
IPSC Century Therapeutics, Inc.2,563,862$3.4M0.65%Added +19%
ISRG Intuitive Surgical, Inc.8,087$3.3M0.63%New
CELC Celcuity Inc.57,880$3.3M0.63%Reduced −41%
IDYA IDEAYA Biosciences, Inc.123,760$3.2M0.62%New
OVID Ovid Therapeutics Inc.1,287,804$3.0M0.58%Reduced −47%
MLYS Mineralys Therapeutics, Inc.200,000$2.8M0.54%Reduced −67%
INSM Insmed Incorporated19,603$2.8M0.54%New
ORKA Oruka Therapeutics, Inc.27,260$2.7M0.51%Reduced −77%
UTHR United Therapeutics Corporation4,646$2.6M0.50%New
DYN Dyne Therapeutics, Inc.154,234$2.5M0.48%New
ATTO Attovia Therapeutics, Inc.138,200$2.2M0.41%New
NRIX Nurix Therapeutics, Inc.137,973$1.9M0.36%New
EDSA Edesa Biotech, Inc.825,000$1.8M0.34%New
ARQT Arcutis Biotherapeutics, Inc.61,189$1.7M0.32%Reduced −38%
MNPR Monopar Therapeutics Inc.23,302$1.6M0.31%Reduced −23%
WHWK Whitehawk Therapeutics, Inc.495,980$1.5M0.30%Reduced −51%
WGS GeneDx Holdings Corp.29,275$1.4M0.28%New
BDSX Biodesix, Inc.141,548$1.2M0.23%Added +102%
AEMD Aethlon Medical, Inc.213,685$1.0M0.20%New
SABS SAB Biotherapeutics, Inc.352,689$1.0M0.20%Added +3%
QNRX Quoin Pharmaceuticals, Ltd.236,234$794K0.15%New
ADRX ADARx Pharmaceuticals, Inc.52,000$736K0.14%New
ANRO Alto Neuroscience Inc21,763$577K0.11%New
STLN Starling Oncology, Inc.156,663$498K<0.1%New
CUE Cue Biopharma, Inc.108,647$489K<0.1%Added +62%
CLRB Cellectar Biosciences, Inc.447,360$395K<0.1%Added +26%
CALC CalciMedica, Inc.248,972$291K<0.1%New
BRVE Braveheart Bio, Inc.10,000$193K<0.1%New
RLMD Relmada Therapeutics, Inc.44,129$137K<0.1%Reduced −97%
VTGN Vistagen Therapeutics, Inc.80,299$15K<0.1%Added +5%

Sold out in Q3 2026

StockShares held at Q2 2026Worth today
TYRA Tyra Biosciences, Inc.632,754$12.5M
AMLX Amylyx Pharmaceuticals, Inc.384,304$10.1M
KOD Kodiak Sciences Inc.75,872$7.4M
CLYM Climb Bio Inc742,745$6.9M
CLDX Celldex Therapeutics, Inc.178,412$5.0M
IVA Inventiva S.A.1,426,320$4.9M
DFTX Definium Therapeutics, Inc.137,124$4.0M
ASMB Assembly Biosciences, Inc.170,378$3.8M
PSNL Personalis, Inc.247,783$3.6M
ACAD Acadia Pharmaceuticals Inc.143,167$2.5M
CMPS COMPASS Pathways plc284,769$2.5M
SLDB Solid Biosciences Inc.358,780$2.3M
EQ Equillium, Inc.2,016,607$2.3M
BIOA BioAge Labs, Inc.464,171$2.2M
AXSM Axsome Therapeutics, Inc.15,375$2.1M
PTGX Protagonist Therapeutics, Inc.16,303$2.0M
SPRB Spruce Biosciences, Inc.41,388$1.7M
RAPP Rapport Therapeutics, Inc.66,582$1.6M
GLUE Monte Rosa Therapeutics, Inc.153,544$1.4M
MPLT MapLight Therapeutics, Inc.106,906$686K
GPCR Structure Therapeutics Inc.38,178$654K
ALMS Alumis Inc.135,736$588K
SION Sionna Therapeutics, Inc.59,426$176K
TENX Tenax Therapeutics, Inc.96,273$134K
EYPT EyePoint, Inc.338,471$89K